• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nature's Sunshine Appoints Steven Fasching to Board of Directors

    11/11/24 4:05:00 PM ET
    $DECK
    $NATR
    Shoe Manufacturing
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DECK alert in real time by email

    Steven Fasching, Director

    LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors.

    "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Steve's experience in finance will strengthen our leadership as we continue the transformation of our business."

    Since June 2018, Fasching has served as the Chief Financial Officer of Deckers Brands (NYSE:DECK), which includes iconic brands such as UGG®, Hoka® and Teva®. Fasching has held other senior positions at Deckers Brands since August 2011, including Vice President, Strategy & Investor Relations and Vice President, Strategic Financial Planning. Fasching has over 30 years of experience in long-term financial and strategic planning for multi-billion-dollar organizations. Fasching received a B.S. degree in Business Administration from Pepperdine University and an M.B.A. from The Anderson School of Management at UCLA. He also completed The Executive Program for Prospective Chief Financial Officers through the University of Chicago Booth School of Business.

    About Nature's Sunshine

    Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the Company can be obtained at its website, www.naturessunshine.com.

    Investor Relations

    Gateway Group, Inc.

    Cody Slach

    1-949-574-3860

    [email protected]

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/851f1698-5928-4576-8d35-745869a4dcdf



    Primary Logo

    Get the next $DECK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DECK
    $NATR

    CompanyDatePrice TargetRatingAnalyst
    Deckers Outdoor Corporation
    $DECK
    10/24/2025$120.00 → $105.00Market Perform
    Telsey Advisory Group
    Deckers Outdoor Corporation
    $DECK
    9/18/2025$100.00Underperform
    Bernstein
    Deckers Outdoor Corporation
    $DECK
    7/25/2025$120.00 → $128.00Buy
    Needham
    Deckers Outdoor Corporation
    $DECK
    7/2/2025$90.00Sell
    Goldman
    Deckers Outdoor Corporation
    $DECK
    6/13/2025Hold
    Argus
    Deckers Outdoor Corporation
    $DECK
    5/23/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Deckers Outdoor Corporation
    $DECK
    5/23/2025$110.00Outperform → In-line
    Evercore ISI
    Deckers Outdoor Corporation
    $DECK
    5/23/2025$120.00Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $DECK
    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nature's Sunshine Reports Strong Third Quarter 2025 Results

    Net Sales up 12% to $128.3 Million, GAAP EPS up 30% to $0.30Adjusted EBITDA up 42% to $15.2 MillionRaised Full-Year Outlook LEHI, Utah, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 12% to $128.3 million compared to $114.6 million (up 10% in constant currency).Gross profit margin increased 200 basis points to 73.3% compared to 71.3%.GAAP net income attributable to common shareholders was $5.3 million, o

    11/6/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deckers Brands Reports Second Quarter Fiscal Year 2026 Financial Results

    Second Quarter FY 2026 Revenue Increased 9% to $1.43 Billion Second Quarter FY 2026 Diluted EPS Increased 14% to $1.82 Company Provides Full Fiscal Year 2026 Guidance Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced financial results for the second fiscal quarter ended September 30, 2025. The Company also provided its financial outlook for the full fiscal year ending March 31, 2026. "HOKA and UGG again delivered double-digit growth in the second quarter, reflecting strong performance and international momentum for these powerful brands," said Stefano Caroti, President and Chief Ex

    10/23/25 4:05:00 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Nature's Sunshine Sets Third Quarter 2025 Conference Call for Thursday, November 6, 2025, at 5:00 p.m. ET

    LEHI, Utah, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, November 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, November 6, 2025Time: 5:00 p.m. Eastern time (3:00 p

    10/23/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Deckers Outdoor with a new price target

    Telsey Advisory Group reiterated coverage of Deckers Outdoor with a rating of Market Perform and set a new price target of $105.00 from $120.00 previously

    10/24/25 7:55:02 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Bernstein initiated coverage on Deckers Outdoor with a new price target

    Bernstein initiated coverage of Deckers Outdoor with a rating of Underperform and set a new price target of $100.00

    9/18/25 8:39:58 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Needham reiterated coverage on Deckers Outdoor with a new price target

    Needham reiterated coverage of Deckers Outdoor with a rating of Buy and set a new price target of $128.00 from $120.00 previously

    7/25/25 8:03:57 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    SEC Filings

    View All

    SEC Form 10-Q filed by Nature's Sunshine Products Inc.

    10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    11/6/25 5:11:13 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    11/6/25 4:44:52 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Deckers Outdoor Corporation

    SCHEDULE 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

    11/5/25 11:30:17 AM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Global Supply Chain Gonzalez Martin A. converted options into 5,795 shares and covered exercise/tax liability with 1,673 shares, increasing direct ownership by 6% to 69,640 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    11/6/25 4:42:37 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, General Counsel Brower Nathan G converted options into 3,243 shares and covered exercise/tax liability with 985 shares, increasing direct ownership by 5% to 50,535 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    11/6/25 4:42:10 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP & Chief Financial Officer Jones Leslie Shane covered exercise/tax liability with 1,756 shares and converted options into 4,004 shares, increasing direct ownership by 2% to 108,592 units (SEC Form 4)

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    11/6/25 4:40:38 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Davis Cindy L bought $200,319 worth of shares (1,825 units at $109.76), increasing direct ownership by 16% to 13,340 units (SEC Form 4)

    4 - DECKERS OUTDOOR CORP (0000910521) (Issuer)

    6/6/25 7:31:48 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    $DECK
    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

    SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

    4/10/24 2:03:52 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    SEC Form SC 13G/A filed by Deckers Outdoor Corporation (Amendment)

    SC 13G/A - DECKERS OUTDOOR CORP (0000910521) (Subject)

    2/13/24 5:02:34 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/12/24 10:37:49 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    Financials

    Live finance-specific insights

    View All

    Nature's Sunshine Reports Strong Third Quarter 2025 Results

    Net Sales up 12% to $128.3 Million, GAAP EPS up 30% to $0.30Adjusted EBITDA up 42% to $15.2 MillionRaised Full-Year Outlook LEHI, Utah, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 12% to $128.3 million compared to $114.6 million (up 10% in constant currency).Gross profit margin increased 200 basis points to 73.3% compared to 71.3%.GAAP net income attributable to common shareholders was $5.3 million, o

    11/6/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deckers Brands Reports Second Quarter Fiscal Year 2026 Financial Results

    Second Quarter FY 2026 Revenue Increased 9% to $1.43 Billion Second Quarter FY 2026 Diluted EPS Increased 14% to $1.82 Company Provides Full Fiscal Year 2026 Guidance Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced financial results for the second fiscal quarter ended September 30, 2025. The Company also provided its financial outlook for the full fiscal year ending March 31, 2026. "HOKA and UGG again delivered double-digit growth in the second quarter, reflecting strong performance and international momentum for these powerful brands," said Stefano Caroti, President and Chief Ex

    10/23/25 4:05:00 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Nature's Sunshine Sets Third Quarter 2025 Conference Call for Thursday, November 6, 2025, at 5:00 p.m. ET

    LEHI, Utah, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Thursday, November 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, November 6, 2025Time: 5:00 p.m. Eastern time (3:00 p

    10/23/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DECK
    $NATR
    Leadership Updates

    Live Leadership Updates

    View All

    Nature's Sunshine Appoints Kenneth Romanzi as CEO

    Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025. Mr. Romanzi is an experienced CEO and operator with

    10/15/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Deckers Brands Nominates Patrick J. Grismer to Board of Directors

    Dave Powers to Retire from the Board After Over Nine Years of Service Deckers Brands (NYSE:DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced the nomination of Patrick J. Grismer for election to its Board of Directors (the "Board") at the Company's 2025 Annual Meeting of Stockholders to be held on September 8, 2025 (the "Annual Meeting"). In connection with Mr. Grismer's nomination and as previously announced, Dave Powers will not stand for reelection to the Board at the Annual Meeting, retiring after more than nine years of service as a director. Mr. Grismer brings over 35 years of financial leadership experie

    7/24/25 4:10:00 PM ET
    $DECK
    Shoe Manufacturing
    Consumer Discretionary

    Nature's Sunshine Announces Leadership Transition Plan

    Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the "Board") of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr. Moorehead will also resign as a member of the Board of Directors. The Nature's Sunshine Board ha

    6/2/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care